Electroconvulsive therapy increases temporal gray matter volume and cortical thickness

European Neuropsychopharmacology

Volumn 26, Issue 3, 2016, Pages 506-517

  Sartorius, Alexander ^a   Demirakca, Traute ^a   Böhringer, Andreas ^a   Clemm von Hohenberg, Christian ^a   Aksay, Suna Su ^a   Bumb, Jan Malte ^a   Kranaster, Laura ^a   Ende, Gabriele ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Amygdala; Cortical thickness; Depression; Electroconvulsive therapy; Hippocampus; VBM

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; GRAY MATTER; HABENULA; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEMPORAL CORTEX; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; DIAGNOSTIC IMAGING; IMAGE PROCESSING; LONGITUDINAL STUDY; MENTAL DISORDERS; ORGAN SIZE; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; CROSS-SECTIONAL STUDIES; ELECTROCONVULSIVE THERAPY; FEMALE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MIDDLE AGED; ORGAN SIZE; RETROSPECTIVE STUDIES; TEMPORAL LOBE;

EID: 84953776551     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.12.036     Document Type: Article

References (79)

1. Abrams, R., 2002. The seizure generalization hypothesis. In: Electroconvulsive Therapy. Oxford University Press, Oxford, p. 218.
2. Abrams R., Taylor M.A. Diencephalic stimulation and the effects of ECT in endogenous depression. Br. J. Psychiatry 1976, 129:482-485.
3. Angelucci F., Aloe L., Jimenez-Vasquez P., Mathe A.A. Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J. ECT 2002, 18:138-143.
4. Arnone D., McIntosh A.M., Ebmeier K.P., Munafo M.R., Anderson I.M. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur. Neuropsychopharmacol. 2012, 22:1-16.
5. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
6. Bergouignan L., Chupin M., Czechowska Y., Kinkingnehun S., Lemogne C., Le Bastard G., Lepage M., Garnero L., Colliot O., Fossati P. Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression?. Neuroimage 2009, 45:29-37.
7. Biedermann S.V., Fuss J., Steinle J., Auer M.K., Dormann C., Falfan-Melgoza C., Ende G., Gass P., Weber-Fahr W. The hippocampus and exercise: histological correlates of MR-detected volume changes. Brain Struct. Funct 2014.
8. Biedermann S.V., Weber-Fahr W., Demirakca T., Tunc-Skarka N., Hoerst M., Henn F., Sartorius A., Ende G. (31) P RINEPT MRSI and VBM reveal alterations in brain aging associated with major depression. Magn. Reson. Med. 2015, 73:1390-1400.
9. Biedermann S., Fuss J., Zheng L., Sartorius A., Falf+ín-Melgoza C., Demirakca T., Gass P., Ende G., Weber-Fahr W. In vivo voxel based morphometry: detection of increased hippocampal volume and decreased glutamate levels in exercising mice. Neuroimage 2012, 61:1206-1212.
10. Bolwig T.G. How does electroconvulsive therapy work? Theories on its mechanism. Can. J. Psychiatry 2011, 56:13-18.
11. Bouckaert F., Sienaert P., Obbels J., Dols A., Vandenbulcke M., Stek M., Bolwig T. ECT: its brain enabling effects: a review of electroconvulsive therapy-induced structural brain plasticity. J. ECT 2014, 30:143-151.
12. Bumb J.M., Aksay S.S., Janke C., Kranaster L., Geisel O., Gass P., Hellweg R., Sartorius A. Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 2015, 265:227-232.
13. Burke J., McQuoid D.R., Payne M.E., Steffens D.C., Krishnan R.R., Taylor W.D. Amygdala volume in late-life depression: relationship with age of onset. Am. J. Geriatr. Psychiatry 2012, 19:771-776.
14. Campbell S., Marriott M., Nahmias C., MacQueen G.M. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am. J. Psychiatry 2004, 161:598-607.
15. Cole J., Costafreda S.G., McGuffin P., Fu C.H. Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. J. Affect. Disord. 2011, 134:483-487.
16. Dukart J., Regen F., Kherif F., Colla M., Bajbouj M., Heuser I., Frackowiak R.S., Draganski B. Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders. Proc. Natl. Acad. Sci. USA 2014, 111:1156-1161.
17. Fink M., Taylor M.A. Electroconvulsive therapy: evidence and challenges. J. Am. Med. Assoc. 2007, 298:330-332.
18. Folkerts H. The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy. Eur. Arch. Psychiatry Clin. Neurosci. 1996, 246:155-164.
19. Frodl T., Jager M., Smajstrlova I., Born C., Bottlender R., Palladino T., Reiser M., Moller H.J., Meisenzahl E.M. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J. Psychiatry Neurosci. 2008, 33:423-430.
20. Frodl T., O'Keane V. How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol. Dis. 2013, 52:24-37.
21. Frodl T., Meisenzahl E., Zetzsche T., Bottlender R., Born C., Groll C., Jäger M., Leinsinger G., Hahn K., Möller H.J. Enlargement of the amygdala in patients with a first episode of major depression. Biol. Psychiatry 2002, 51:708-714.
22. Gass N., Cleppien D., Zheng L., Schwarz A.J., Meyer-Lindenberg A., Vollmayr B., Weber-Fahr W., Sartorius A. Functionally altered neurocircuits in a rat model of treatment-resistant depression show prominent role of the habenula. Eur. Neuropsychopharmacol. 2014, 24:381-390.
23. Gersner R., Gal R., Levit O., Moshe H., Zangen A. Inherited behaviors, BDNF expression and response to treatment in a novel multifactorial rat model for depression. Int. J. Neuropsychopharmacol. 2014, 17:945-955.
24. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001, 14:21-36.
25. Hamilton J.P., Siemer M., Gotlib I.H. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol. Psychiatry 2009, 13:993-1000.
26. Hausner L., Damian M., Sartorius A., Frolich L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J. Clin. Psychiatry 2011, 72:91-97.
27. Henn F.A., Vollmayr B., Sartorius A. Mechanisms of depression: the role of neurogenesis. Drug. Discov. Today: Dis. Mech. 2004, 1:407-411.
28. Hoshaw B.A., Malberg J.E., Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 2005, 1037:204-208.
29. Hoyer C., Kranaster L., Janke C., Sartorius A. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur. Arch. Psychiatry Clin. Neurosci. 2014, 264:255-261.
30. Hoyer C., Kranaster L., Sartorius A., Hellweg R., Gass P. Long-term course of brain-derived neurotrophic factor serum levels in a patient treated with deep brain stimulation of the lateral habenula. Neuropsychobiology 2012, 65:147-152.
31. Hutton C., De Vita E., Ashburner J., Deichmann R., Turner R. Voxel-based cortical thickness measurements in MRI. Neuroimage 2008, 40:1701-1710.
32. Janke C., Bumb J.M., Aksay S.S., Thiel M., Kranaster L., Sartorius A. Ketamine as anesthetic agent in electroconvulsion therapy. Anaesthesist 2015.
33. Jones S.E., Buchbinder B.R., Aharon I. Three-dimensional mapping of cortical thickness using Laplace[U+05F3]s equation. Hum. Brain Mapp. 2000, 11:12-32.
34. Joshi S.H., Espinoza R.T., Pirnia T., Shi J., Wang Y., Ayers B., Leaver A., Woods R.P., Narr K.L. Structural plasticity of the hippocampus and amygdala induced by electroconvulsive therapy in major depression. Biol. Psychiatry 2015.
35. Kessler R.C., Bromet E.J. The epidemiology of depression across cultures. Annu. Rev. Public Health 2013, 34:119-138.
36. Kiening K., Sartorius A. A new translational target for deep brain stimulation to treat depression. EMBO Mol. Med. 2013, 5:1151-1153.
37. Klauschen F., Goldman A., Barra V., Meyer-Lindenberg A., Lundervold A. Evaluation of automated brain MR image segmentation and volumetry methods. Hum. Brain Mapp. 2009, 30:1310-1327.
38. Kronenberg G., Tebartz van Elst L., Regen F., Deuschle M., Heuser I., Colla M. Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression. J. Psychiatr. Res. 2009, 43:1112-1117.
39. Lang U.E., Jockers-Scherubl M.C., Hellweg R. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J. Neural Transm. 2004, 111:387-411.
40. Lange C., Irle E. Enlarged amygdala volume and reduced hippocampal volume in young women with major depression. Psychol. Med. 2004, 34:1059-1064.
41. Lekwauwa R.E., McQuoid D.R., Steffens D.C. Hippocampal volume as a predictor of short-term ECT outcomes in older patients with depression. Am. J. Geriatr. Psychiatry 2005, 13:910-913.
42. Maass A., Duzel S., Goerke M., Becke A., Sobieray U., Neumann K., Lovden M., Lindenberger U., Backman L., Braun-Dullaeus R., Ahrens D., Heinze H.J., Muller N.G., Duzel E. Vascular hippocampal plasticity after aerobic exercise in older adults. Mol. Psychiatry 2014.
43. McKinnon M.C., Yucel K., Nazarov A., MacQueen G.M. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J. Psychiatry Neurosci. 2009, 34:41-54.
44. Merkl A., Heuser I., Bajbouj M. Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations. Exp. Neurol. 2009, 219:20-26.
45. Moscrip T.D., Terrace H.S., Sackeim H.A., Lisanby S.H. Randomized controlled trial of the cognitive side-effects of magnetic seizure therapy (MST) and electroconvulsive shock (ECS). Int. J. Neuropsychopharmacol. 2006, 9:1-11.
46. Murray C.J., Lopez A.D. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 1996, 274:740-743.
47. Nordanskog P., Dahlstrand U., Larsson M.R., Larsson E.M., Knutsson L., Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J. ECT 2010, 26:62-67.
48. Nordanskog P., Larsson M.R., Larsson E.M., Johanson A. Hippocampal volume in relation to clinical and cognitive outcome after electroconvulsive therapy in depression. Acta Psychiatr. Scand. 2014, 129:303-311.
49. Nordgren M., Karlsson T., Svensson M., Koczy J., Josephson A., Olson L., Tingstrom A., Brene S. Orchestrated regulation of Nogo receptors, LOTUS, AMPA receptors and BDNF in an ECT model suggests opening and closure of a window of synaptic plasticity. PLoS One 2013, 8:e78778.
50. O'Donovan S., Dalton V., Harkin A., McLoughlin D.M. Effects of brief pulse and ultrabrief pulse electroconvulsive stimulation on rodent brain and behaviour in the corticosterone model of depression. Int. J. Neuropsychopharmacol. 2014, 17:1477-1486.
51. Pajonk F.G., Wobrock T., Gruber O., Scherk H., Berner D., Kaizl I., Kierer A., Muller S., Oest M., Meyer T., Backens M., Schneider-Axmann T., Thornton A.E., Honer W.G., Falkai P. Hippocampal plasticity in response to exercise in schizophrenia. Arch. Gen. Psychiatry 2010, 67:133-143.
52. Phillips J.L., Batten L.A., Tremblay P., Aldosary F., Blier P. A prospective, longitudinal study of the effect of remission on cortical thickness and hippocampal volume in patients with treatment-resistant depression. Int. J. Neuropsychopharmacol 2015.
53. Ranft K., Dobrowolny H., Krell D., Bielau H., Bogerts B., Bernstein H.G. Evidence for structural abnormalities of the human habenular complex in affective disorders but not in schizophrenia. Psychol. Med. 2010, 40:557-567.
54. Romanczuk-Seiferth N., Pohland L., Mohnke S., Garbusow M., Erk S., Haddad L., Grimm O., Tost H., Meyer-Lindenberg A., Walter H., Wustenberg T., Heinz A. Larger amygdala volume in first-degree relatives of patients with major depression. Neuroimage Clin. 2014, 5:62-68.
55. Rush A.J., Trivedi M., Fava M. Depression, IV: STAR*D treatment trial for depression. Am. J. Psychiatry 2003, 160:237.
56. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., Niederehe G., Thase M.E., Lavori P.W., Lebowitz B.D., McGrath P.J., Rosenbaum J.F., Sackeim H.A., Kupfer D.J., Luther J., Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 2006, 163:1905-1917.
57. Rush A.J., Trivedi M.H., Wisniewski S.R., Stewart J.W., Nierenberg A.A., Thase M.E., Ritz L., Biggs M.M., Warden D., Luther J.F., Shores-Wilson K., Niederehe G., Fava M. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. 2006, 354:1231-1242.
58. Sartorius A., Bumb J.M., Aksay S.S., Gass P., Hellweg R., Kranaster L. ECT seizure quality and serum BDNF, revisited. Eur. Arch. Psychiatry Clin. Neurosci 2015.
59. Sartorius A., Hellweg R., Litzke J., Vogt M., Dormann C., Vollmayr B., Danker-Hopfe H., Gass P. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009, 42:270-276.
60. Sartorius A., Henn F.A. Deep brain stimulation of the lateral habenula in treatment resistant major depression. Med. Hypotheses 2007, 69:1305-1308.
61. Sartorius A., Hewer W. Safe performance of ECT in severely ill patients: a retrospective study. Eur. J. Psychiatry 2007, 21:237-247.
62. Sartorius A., Hoyer C., Kiening K., Meyer-Lindenberg A. Medial forebrain bundle stimulation-speed access to an old or entry into a new depression neurocircuit?. Biol. Psychiatry 2013, 74:e43.
63. Sartorius A., Kiening K.L., Kirsch P., von Gall C.C., Haberkorn U., Unterberg A.W., Henn F.A., Meyer-Lindenberg A. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol. Psychiatry 2010, 67:e9-e11.
64. Sartorius A., Munoz-Canales E.M., Krumm B., Krier A., Andres F.J., Bender H.J., Henn F.A. ECT anesthesia: the lighter the better?. Pharmacopsychiatry 2006, 39:201-204.
65. Sartorius A., Vollmayr B., Neumann-Haefelin C., Ende G., Hoehn M., Henn F.A. Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment. Neuroreport 2003, 14:2199-2201.
66. Savitz J.B., Nugent A.C., Bogers W., Roiser J.P., Bain E.E., Neumeister A., Zarate C.A., Manji H.K., Cannon D.M., Marrett S., Henn F., Charney D.S., Drevets W.C. Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study. Biol. Psychiatry 2011, 69:336-343.
67. Sebag-Montefiore S.E. Letter: flurothyl (Indoklon) in depression. Br. J. Psychiatry 1974, 124:616-617.
68. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 1996, 93:3908-3913.
69. Swartz C.M., Larson G. Generalization of the effects of unilateral and bilateral ECT. Am. J. Psychiatry 1986, 143:1040-1041.
70. Taylor S.M. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J. ECT 2008, 24:160-165.
71. Ten Doesschate F., van Eijndhoven P., Tendolkar I., van Wingen G.A., van Waarde J.A. Pre-treatment amygdala volume predicts electroconvulsive therapy response. Front. Psychiatry 2014, 5:169.
72. Tendolkar I., van Beek M., van O., Mulder I., Janzing M., Voshaar J., van Eijndhoven, P.R.O. Electroconvulsive therapy increases hippocampal and amygdala volume in therapy refractory depression: a longitudinal pilot study. Psychiatry Res. 2013, 214:197-203.
73. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., Norquist G., Howland R.H., Lebowitz B., McGrath P.J., Shores-Wilson K., Biggs M.M., Balasubramani G.K., Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 2006, 163:28-40.
74. Ullsperger M., von Cramon D.Y. Error monitoring using external feedback: specific roles of the habenular complex, the reward system, and the cingulate motor area revealed by functional magnetic resonance imaging. J. Neurosci. 2003, 23:4308-4314.
75. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., Murray C.J. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 2004, 184:386-392.
76. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 2004, 161:1957-1966.
77. Weber T., Baier V., Lentz K., Herrmann E., Krumm B., Sartorius A., Kronenberg G., Bartsch D. Genetic fate mapping of type-1 stem cell-dependent increase in newborn hippocampal neurons after electroconvulsive seizures. Hippocampus 2013, 23:1321-1330.
78. Whitford T.J., Farrow T.F., Gomes L., Brennan J., Harris A.W., Williams L.M. Grey matter deficits and symptom profile in first episode schizophrenia. Psychiatry Res. 2005, 139:229-238.
79. Winter C., Vollmayr B., Djodari-Irani A., Klein J., Sartorius A. Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression. Behav. Brain Res. 2011, 216:463-465.